EUVIMEDEUVIMED entdecken
Crossref

Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype

Jian-Guo Li, Benjamin E Blass, Domenico Praticò

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-220869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Jian-Guo Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Center at Temple, Lewis Katz School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The endosomal retromer complex system is a key controller for trafficking of proteins. Downregulation of its recognition core proteins, such as VPS35, is present in Alzheimer’s disease (AD) brain, whereas its normalization prevents the development of AD pathology in a transgenic model with amyloid-β deposits and tau tangles.

Objective

Assess the effect of targeting VPS35 after the AD pathology and memory impairments have developed.

Methods

Twelve-month-old triple transgenic mice were treated with a small pharmacological chaperone, TPT-172, or vehicle for 14 weeks. At the end of this period, the effect of the drug on their phenotype was evaluated.

Results

While control mice had a decline of learning and memory, the group receiving the chaperone did not. Moreover, when compared with controls the treated mice had significantly less amyloid-β peptides and phosphorylated tau, elevation of post-synaptic protein, and reduction in astrocytes activation.

Conclusion

Taken together, our findings demonstrate that pharmacologic stabilization of the retromer recognition core is beneficial also after the AD-like pathologic phenotype is established.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMiceAnimalstau ProteinsAmyloid beta-PeptidesMice, TransgenicPhenotypeDisease Models, AnimalAmyloid beta-Protein PrecursorVesicular Transport Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-βpharmacological chaperoneretromer complextau protein

Substanzen

tau ProteinsAmyloid beta-PeptidesAmyloid beta-Protein PrecursorVps35 protein, mouseVesicular Transport Proteins

Autor:innen und Institutionen

  • Alzheimer's Center at Temple, Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Moulder Center for Drug Discovery Research, School of Pharmacy, Temple University, Philadelphia, PA, USA.

Zitieren

APA

Li, J. G., Blass, B. E., & Praticò, D. (2023). Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220869

Vancouver

Li JG, Blass BE, Praticò D. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-220869

BibTeX
@article{Li2023,
  author = {Li, Jian-Guo and Blass, Benjamin E and Praticò, Domenico},
  title = {Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-220869}
}
Kostenlos starten →